Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Bruxelles  >  MDxHealth    MDXH   BE0003844611

MDXHEALTH

(MDXH)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Bruxelles
04/12/2019 04/15/2019 04/16/2019 04/17/2019 04/18/2019 Date
1.442(c) 1.528(c) 1.554(c) 1.556(c) 1.576(c) Last
57 048 184 890 49 686 70 783 47 228 Volume
-0.14% +5.96% +1.70% +0.13% +1.29% Change
More quotes
Financials (USD)
Sales 2019 27,7 M
EBIT 2019 -18,9 M
Net income 2019 -19,0 M
Finance 2019 31,0 M
Yield 2019 -
Sales 2020 37,3 M
EBIT 2020 -7,27 M
Net income 2020 -14,5 M
Finance 2020 17,0 M
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020
EV / Sales2019 2,74x
EV / Sales2020 2,41x
Capitalization 107 M
More Financials
Company
MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic assays and service testing for cancer assessment and the personalized treatment of patients. The activity is organized around two product families: - Clinical Molecular Diagnostics (ClinicalMDx)... 
More about the company
Surperformance© ratings of MDxHealth
Trading Rating : Investor Rating :
More Ratings
Latest news on MDXHEALTH
03/19MDXHEALTH : Announces Positive Data from Pan-European Clinical Validation Study ..
AQ
03/18MDXHEALTH (R) : MDxHealth Announces Positive Data from Pan-European Clinical Val..
GL
03/05MDXHEALTH : SelectMDx® Liquid Biopsy Test for Prostate Cancer Included in the 20..
GL
02/28MDXHEALTH : Reports Financial Year 2018 Results and Provides Outlook for 2019
AQ
02/28MDXHEALTH (R) : MDxHealth Reports Financial Year 2018 Results and Provides Outlo..
PU
02/28MDXHEALTH (R) : MDxHealth Reports Financial Year 2018 Results and Provides Outl..
GL
02/20MDxHealth - MDxHealth Appoints Michael K. McGarrity as CEO
AQ
02/19MDXHEALTH (R) : MDxHealth Appoints Michael K. McGarrity as CEO
GL
02/18MDXHEALTH : Announces Presentation of Positive Data for SelectMDx and ConfirmMDx..
AQ
02/16MDXHEALTH (R) : MDxHealth Announces Presentation of Positive Data for SelectMDx ..
AQ
More news
Analyst Recommendations on MDXHEALTH
More recommendations
Sector news : Biotechnology & Medical Research - NEC
04/16GILEAD SCIENCES : Insitro to Collaborate on Nonalcoholic Steatohepatitis
DJ
04/15PATRICK THOMAS : Novartis Files Application for Macular Degeneration Treatment
DJ
04/12GILEAD SCIENCES : Novo Nordisk Plan NASH Collaboration
DJ
04/08GSK wins U.S. nod for two-drug HIV combination
RE
04/08Sanofi, Alnylam Complete Research Phase of Rare Disease Alliance
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart MDXHEALTH
Duration : Period :
MDxHealth Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MDXHEALTH
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 1,98 $
Spread / Average Target 12%
EPS Revisions
Managers
NameTitle
Jan Groen President, CEO & Executive Director
Koen Hoffman Chairman
Jean-Marc Roelandt Chief Financial Officer & Executive Vice President
Michael K. Brawer Chief Medical Officer & Executive Vice President
Rudi M. Mariën Non-Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
MDXHEALTH-14.81%107
IQVIA HOLDINGS INC14.50%26 285
CELLTRION, INC.--.--%24 574
LONZA GROUP16.76%21 828
INCYTE CORPORATION16.31%15 847
EXACT SCIENCES CORPORATION46.13%11 596